FIELD: medicine.
SUBSTANCE: method involves obtaining mononuclear blood cells containing nucleic acid of given individuum, measuring at least one nucleic acid content selected from a group containing the nucleic acid(s), its fragment or a nucleic acid complementary to the given one, determining gene(s) showing expression changed when schizophrenia is available, nucleic acid(s), its fragment or a nucleic acid complementary to the given one, determining gene(s) showing expression changed when schizophrenia is in progress, in said mononuclear blood cells. Statistical significance of quantitative level(s) is to be determined.
EFFECT: high accuracy of diagnosis.
20 cl, 11 tbl
